The biotechnology company discovers and manufactures treatments for autoimmune disorders, neurodegenerative diseases, and hemophilia. It also makes and sells biosimilars of advanced biologics.
Looking for leads, investment insights, or competitive intelligence?
News about Biogen
Nightstar developed a treatment for a rare eye disorder.
In a clinical trial, researchers were able to reduce existing brain plaques and slow the formation of new ones.
Shares of biotech giant Biogen and partner Eisai were both up 20% Friday.
There still aren't any truly effective drugs for Alzheimer's or dementia.